Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)

30.74 +0.71 (+2.36%) At close: 03:04PM CST

Shenzhen Weiguang Biological Products Co., Ltd.

No. 3402, Guangqiao Avenue
Guangming Street Guangming District
Shenzhen 518107
China
86 755 2740 2880
https://www.szwg.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 796

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Caiping Guo	GM & Director	N/A	N/A	1971
Mr. Qiang Xu	Deputy General Manager	N/A	N/A	1964
Mr. Xin Zhang	Deputy GM, Board Secretary & Director	N/A	N/A	1962

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous human immunoglobulin (pH4), rabies immunoglobulin, human fibrinogen, coagulation factor, trace proteins, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.

Corporate governance

Shenzhen Weiguang Biological Products Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.